by admin_63069 | Jun 6, 2023 | Related Topics
Diversity in clinical trials is needed to better understand prostate cancer disparities and the importance of evolving urological practices to cater to the changing patient demographic.
by admin_63069 | Jun 3, 2023 | Related Topics
PMSA PET is a novel way of diagnosing and treating patients with prostate cancer who have advanced disease.
by admin_63069 | May 30, 2023 | Related Topics
Expert oncologists briefly review the current treatment paradigm of metastatic castration-resistant prostate cancer (mCRPC).
by admin_63069 | May 26, 2023 | Related Topics
Kelly L. Stratton, MD, FACS, recaps several presentations on prostate cancer from the 2023 American Urological Association Annual Meeting in Chicago, Illinois.
by admin_63069 | May 23, 2023 | Related Topics
The importance of quality of life and multi-disciplinary care
by admin_63069 | May 20, 2023 | Related Topics
Preclinical work identifies better targets and recruits more immune cells to make CAR-T therapy work for solid tumors.
